Novacyt (NCYT) Competitors

EKF Diagnostics (LON:EKF) and Novacyt (LON:NCYT) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings, community ranking and dividends.

Does the MarketBeat Community prefer EKF or NCYT?

EKF Diagnostics received 291 more outperform votes than Novacyt when rated by MarketBeat users. Likewise, 76.76% of users gave EKF Diagnostics an outperform vote while only 58.06% of users gave Novacyt an outperform vote.

Company	Underperform	Outperform
EKF Diagnostics	Outperform Votes 327 76.76%	Underperform Votes 99 23.24%
Novacyt	Outperform Votes 36 58.06%	Underperform Votes 26 41.94%

Do analysts recommend EKF or NCYT?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
EKF Diagnostics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Novacyt	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Which has stronger valuation & earnings, EKF or NCYT?

EKF Diagnostics has higher revenue and earnings than Novacyt. Novacyt is trading at a lower price-to-earnings ratio than EKF Diagnostics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
EKF Diagnostics	£50.95M	2.73	£4.78M	£0.01	3,060.00
Novacyt	£18.56M	2.17	-£37.36M	-£0.52	-109.81

Does the media prefer EKF or NCYT?

In the previous week, EKF Diagnostics had 3 more articles in the media than Novacyt. MarketBeat recorded 3 mentions for EKF Diagnostics and 0 mentions for Novacyt. EKF Diagnostics' average media sentiment score of 0.47 beat Novacyt's score of 0.00 indicating that EKF Diagnostics is being referred to more favorably in the media.

Company	Overall Sentiment
EKF Diagnostics	Neutral
Novacyt	Neutral

Which has more risk and volatility, EKF or NCYT?

EKF Diagnostics has a beta of 0.57, suggesting that its stock price is 43% less volatile than the S&P 500. Comparatively, Novacyt has a beta of -1.86, suggesting that its stock price is 286% less volatile than the S&P 500.

Do insiders & institutionals have more ownership in EKF or NCYT?

70.3% of EKF Diagnostics shares are held by institutional investors. Comparatively, 0.1% of Novacyt shares are held by institutional investors. 5.2% of EKF Diagnostics shares are held by company insiders. Comparatively, 3.1% of Novacyt shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Is EKF or NCYT more profitable?

EKF Diagnostics has a net margin of 9.37% compared to Novacyt's net margin of -202.80%. EKF Diagnostics' return on equity of 7.58% beat Novacyt's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
EKF Diagnostics	9.37%	7.58%	5.27%
Novacyt	-202.80%	-42.04%	-27.98%

Summary

EKF Diagnostics beats Novacyt on 15 of the 15 factors compared between the two stocks.